Cormorant Asset Management, LP Q2 2021 Filing

Filed August 16, 2021

Portfolio Value

$2.9B

Holdings

103

Report Date

Q2 2021

Filing Type

13F-HR

All Holdings (103 positions)

StockValue
—CEREVEL THERAPEUTICS HLDNG I
$278K
NUVB/WSNUVATION BIO INC
$217K
—OUTLOOK THERAPEUTICS INC
$130K
PreviousPage 2 of 2